Skip to Content

Refocus Group Inc RFCS

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Refocus Group Inc is a medical device company involved in researching and developing innovative treatments for human vision disorders, particularly for the treatment of presbyopia. The company's VisAbility™ Micro-Insert System-the world's first binocular presbyopic treatment that works outside the visual axis, is in clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.

Contact
10210 North Central Expressway, Suite 400
Dallas, TX, 75231
T +1 214 368-0200
Sector Healthcare
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Dec 31, 2015
Stock Type
Employees